Comparison of Ropivacaine With Dexmedetomidine Versus Magnesium Sulphate In Ultrasound Guided Supraclavicular Brachial Plexus Block For Upperlimb Surgeries.

A Comparative Study To Assess The Effectiveness 0.75% Ropivacaine With Dexmedetomidine Versus 0.75% Ropivacaine With Magnesium Sulphate In Ultrasound Guided Supraclavicular Brachial Plexus Block For Upperlimb Surgeries. - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/07/055203

Enrollment

Registered

2023-07-13

Start date

Unknown

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S599- Unspecified injury of elbow and forearm Health Condition 2: S599- Unspecified injury of elbow and forearm

Interventions

Intervention1: Dexmedetomidine and Magnesium sulphate added as adjuvants with 0.75% Ropivacaine Supraclavicular brachial plexus block for upper limb surgeries.: This interventional study is designed

Eligibility

Inclusion criteria

Inclusion criteria: patients undergoing upper limb surgeries under supraclavicular brachial plexus block.Aged between 18 to 65 years and are ASA classes 1 and 2 will be included in the study after obtaining informed consent.

Exclusion criteria

Exclusion criteria: preexisting peripheral neuropathy .Bleeding disorders.Infection at injection site.Allergy to local anesthetics,magnesium sulphate.surgeries lasting more than 3 hours.Patients with history suggestive of arrythmias.patients who do not give consent.

Design outcomes

Secondary

Measure	Time frame
Hemodynamic stabilityTimepoint: monitoring of systolic blood pressure, diastolic blood pressure ,heart rate & oxygen saturation done at o hours,1hour,2hours,3hours,4hours,8hours,12hours,16hours,20hours, 24 hours after administration of supraclavicular brachial plexus block	—

Primary

Measure	Time frame
Time of onset of sensory blockade. Time of onset of motor blockade. Duration of sensory block. duration of motor block .Timepoint: Time of onset of sensory blockade assessed at 0 minute,1 minute,3 minutes,5minutes,7minutes,9 minutes,10 minutes likewise every 2 minutes for 20 minutes Time of onset of motor blockade assessed at 0 minute,1 minute,3 minutes,5 minutes,7 minutes likewise every 2 minutes for 20 minutes Duration of sensory block assessed at 4 hours,8 hours, 12 hours,16 hours,20 hours,24 hours. duration of motor block assessed at 4 hours, 8 hours,12 hours, 16 hours , 20 hours , 24 hours.	—

Measure

Time frame

Time of onset of sensory blockade. Time of onset of motor blockade. Duration of sensory block. duration of motor block .Timepoint: Time of onset of sensory blockade assessed at 0 minute,1 minute,3 minutes,5minutes,7minutes,9 minutes,10 minutes likewise every 2 minutes for 20 minutes Time of onset of motor blockade assessed at 0 minute,1 minute,3 minutes,5 minutes,7 minutes likewise every 2 minutes for 20 minutes Duration of sensory block assessed at 4 hours,8 hours, 12 hours,16 hours,20 hours,24 hours. duration of motor block assessed at 4 hours, 8 hours,12 hours, 16 hours , 20 hours , 24 hours.

—

Countries

India

Contacts

Public ContactDrReshma Balakrishnan

Pushpagiri Institute Of Medical Sciences And Research Centre

shailender2002@gmail.com9446816667

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026